Moderna’s stock jumps after biotech raises sales outlook
What we know so far
MarketWatch (Nov 6, 18:15): The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.
Risk warning: This article is for information only and is not investment advice. Trading forex, CFDs, stocks and crypto carries a high risk of losing money. Prices move fast – check live quotes before you trade.
